PubMed Health⌕ Search

Biomedical subjects

K F Eckerman

Publications and source records attributed to K F Eckerman.

33 records · Page 2Linked to original sources

Electron absorbed fractions and dose conversion factors for marrow and bone by skeletal regions.

The possible inductions of bone cancer and leukemia are the two health effects of primary concern in the irradiation of the skeleton. The relevant target tissues to consider in the dosimetric evaluation have been the cells on or near endosteal surfaces of bone, from which osteosarcomas are thought to arise, and hematopoietic bone marrow, which is associated with leukemia. The complex geometry of the soft tissue-bone intermixture makes calculations of absorbed doses to these target regions a difficult problem. In the case of photon or neutron radiations, charged particle equilibrium may not exist in the vicinity of a soft tissue-bone mineral interface. In this paper, absorbed fraction data are developed for calculations of the dose in the target tissues from electron emitters deposited within the volume or on the surfaces of trabecular bone. The skeletal average absorbed fractions presented are consistent with usage of this quantity in the contemporary dosimetric formulations of the International Commission on Radiological Protection (ICRP). Implementation of the new bone and marrow model is then developed within the context of the calculational schema of the Medical Internal Radiation Dose (MIRD) Committee. Model parameters relevant to the calculation of dose conversion factors (S values) for different regions of the skeleton of individuals of various age are described, and an example calculation is performed for a monoclonal antibody which localizes in the marrow. The utility of these calculations for radiation dose calculations in nuclear medicine is discussed.

Adolescent↗

In vivo biodistribution of 125IPIP and internal dosimetry of 123IPIP radioiodinated agents selective to the muscarinic acetylcholinergic receptor complex.

The development of new radioiodinated ligands for imaging the muscarinic acetylcholinergic complex (mAChR) using single photon emission computed tomography (SPECT) requires the evaluation of human organ doses prior to approval for human use. Animal biodistribution and excretion data were obtained and evaluated for IPIP, a new mAChR agent. Preliminary biodistribution studies were performed on four different stereoisomers of IPIP. A biokinetic model of the Z-(S)-IPIP stereoisomer was constructed for the rat and used to estimate the internal absorbed dose in humans based on an extrapolation of the rat model. The thyroid is the critical organ for this radiopharmaceutical, with an absorbed dose estimate of 2.4 mGy/MBq for both males and females, when labeled with 123I. Even when blocked, the thyroid is still the critical organ, yet with a 90% dose reduction. The heart and brain receive the next highest doses in both males and females. Effective dose estimates for the use of pure 123I-PIP in humans are 0.16 mSv/MBq for males and 0.14 mSv/MBq for females. The biodistribution studies of the Z-(S)-IPIP stereoisomer showed the most promise as a successful agent for imaging muscarinic receptor sites in the heart and brain. IPIP also demonstrated potential as a therapeutic radiopharmaceutical for some colon carcinomas where muscarinic receptor sites are expressed in the tumor cells. These results provide preliminary data for use of IPIP in clinical studies on humans.

Animals↗

Availability of nuclear decay data in electronic form, including beta spectra not previously published.

The unabridged data used in preparing ICRP Publication 38 (1983) and a monograph of the Medical Internal Radiation Dose (MIRD) Committee (Weber et al. 1989) are now available in electronic form. The "ICRP38 collection" contains data on the energies and intensities of radiations emitted by 825 radionuclides (those in ICRP Publication 38 plus 13 from the MIRD monograph), and the "MIRD collection" contains data on 242 radionuclides. Each collection consists of a radiations data file and a beta spectra data file. The radiations data file contains the complete listing of the emitted radiations, their types, mean or unique energies, and absolute intensities for each radionuclide. The beta spectra file contains, for each beta-emitting radionuclide, the probability that a beta particle will be emitted with kinetic energies defined by a standard energy grid. Although summary information from the radiations data files has been published, neither the unabridged data nor the beta spectra have been published. These data files and a data extraction utility, which runs on a personal computer, are available from the Radiation Shielding Information Center at Oak Ridge National Laboratory.

Databases, Factual↗

Bremsstrahlung radiation dose in yttrium-90 therapy applications.

UNLABELLED: The bremsstrahlung component of the decay scheme of beta emitters has been traditionally ignored in internal dosimetry calculations. METHODS: We have estimated the radiation dose from the bremsstrahlung component of the decay scheme of 90Y as a function of distance from a point source in a liquid medium and to body organs from distributed sources of 90Y in the liver and spleen. RESULTS: These estimates agree with measurements of bremsstrahlung dose measured in a Rando phantom, and give an estimate of the importance of this contribution to the overall dosimetry. CONCLUSIONS: The bremsstrahlung radiation absorbed dose contribution from an organ to itself is very small compared to that from the beta dose, but the contribution to other organs is not always negligible, especially when large amounts of 90Y may be involved, as in therapy applications.

Beta Particles↗

An elementary method for implementing complex biokinetic models.

Recent efforts to incorporate greater anatomical and physiological realism into biokinetic models have resulted in many cases in mathematically complex formulations that limit routine application of the models. This paper describes an elementary, computer-efficient technique for implementing complex compartmental models, with attention focused primarily on biokinetic models involving time-dependent transfer rates and recycling. The technique applies, in particular, to the physiologically based, age-specific biokinetic models recommended in Publication No. 56 of the International Commission on Radiological Protection, Age-Dependent Doses to Members of the Public from Intake of Radionuclides.

Age Factors↗

Source inventory limits.

A new set of values has been developed for exempting sealed sources of radioactive materials from inventory. The criteria for exemption are: (a) the annual occupational dose from external radiation at 1 m from the source is approximately 100 microSv (10 mrem) or less; and (b) the source activity is approximately equal to the annual limit on intake by inhalation or less than 4 X 10(7) Bq (1000 microCi). These criteria were selected to correspond to an annual occupational dose of approximately 50 to 500 microSv (5 to 50 mrem) and a small potential annual risk of approximately 1 X 10(-6) to 1 X 10(-5) fatal cancers or less.

Radiation Protection↗

A model of the peritoneal cavity for use in internal dosimetry.

Several therapeutic and diagnostic techniques involve injection of radioactive material into the peritoneal cavity. Estimation of the radiation dose to the surface of the peritoneum or to surrounding organs is hampered by the lack of a suitable source region in the phantom commonly used for such calculations. We have modified the Fisher-Snyder phantom to include a region representing the peritoneal cavity which may be employed to estimate such radiation doses. A geometric model is described which is coordinated with the existing organ regions in the phantom. Specific absorbed fractions (derived by Monte Carlo techniques) for photon emissions originating within the cavity are listed. Photon S-values for several radionuclides which have been administered intraperitoneally are shown. Dose conversion factors for electrons irradiating the peritoneal cavity wall, from either a thin plane or volume source of activity within the cavity, are also given for several nuclides.

Electrons↗

On the relationship between radiation standards for the general public and limitation of lifetime risk.

This paper discusses the relationship between standards for limiting radiation exposures of individuals in the general public and limitation of lifetime risk. Most current radiation standards for the public in the United States specify limits on dose for each year of exposure. Particularly for internal exposures, we show that such standards may correspond poorly with a limit on lifetime risk when the age dependence of radionuclide intakes and dose is taken into account. We then show that standards which specify limits on annual dose averaged over a lifetime, with a subsidiary limit on dose in any year, correspond more closely with a limit on lifetime risk. Finally, we discuss standards for public exposures that are expressed directly as limits on lifetime risk. The development of risk standards would require consideration of age-dependent radiogenic risks and competing risks from all other causes as well as age-dependent dosimetry. We present sample calculations of lifetime risks from acute and chronic intakes that would support such a standard. We suggest that implementation of a standard for lifetime risk would require modification or abandonment of several radiation protection practices embodied in standards which specify limits on dose.

Adolescent↗

A method for estimating the systemic burden of Pu from urinalyses.

It is generally agreed that Langham's model for urinary excretion of Pu substantially overestimates the systemic burden several years after exposure. Improved estimates can be derived from information obtained since the development of that model, including comparative urine and autopsy data for occupationally exposed persons; reanalyzed and updated data for human subjects injected with Pu; and a large body of general physiological and Pu-specific information on the processes governing the behavior of Pu in the body. We examine modeling approaches based on each of these sets of information and show that the three approaches yield fairly consistent estimates of the urinary excretion rate over three decades after contamination of blood. Estimates from the various approaches are unified to obtain a single set of predicted urinary excretion rates that, in effect, is based on all three bodies of information. A simple method is described for using these excretion rates to estimate intakes and systemic burdens of Pu.

Adolescent↗

Electron dose-rate conversion factors for external exposure of the skin from uniformly deposited activity on the body surface.

Dose-rate conversion factors have been calculated for external exposure of the skin from electrons emitted by sources that are deposited uniformly on the body surface. The dose-rate factors are obtained from electron scaled point kernels developed by Berger (Be71; Be73; Be74). The dose-rate factors are calculated at depths of 4, 8, and 40 mg cm-2 below the body surface as recommended by Whitton (Wh73), and at a depth of 7 mg cm-2 as recommended in ICRP Publication 26 (ICRP77). The dependence of the dose-rate factors at selected depths on the energy of the emitted electrons is displayed. The dose-rate factors for selected radionuclides of potential importance in radiological assessments are tabulated.

Beta Particles↗

Increased delivery of tumor-specific monoclonal antibodies to brain after osmotic blood-brain barrier modification in patients with melanoma metastatic to the central nervous system.

We evaluated the delivery of melanoma-specific radiolabeled monoclonal antibody (MAb) Fab fragments in a pilot study of three patients with melanoma metastatic to the central nervous system. Tumor samples demonstrated excellent immunohistochemical reactivity with Fab 96.5, specific for a 97,000-molecular-weight melanoma antigen (p97), or Fab 48.7, specific for a melanoma-associated proteoglycan antigen. All three patients received 131I-labeled tumor-specific Fab (5 to 7 mg, 1 mCi/mg) intravenously. On a separate occasion, two patients received 131I-labeled nonspecific Fab (5 to 7 mg, 1 mCi/mg). There was no uptake of either antibody into the region of the tumor (as documented by gamma camera brain images). However, there was increased uptake in the blood-brain barrier (BBB)-modified areas in all three patients when radiolabeled tumor-specific MAb was administered intravenously in conjunction with osmotic BBB opening. In one patient, the estimated cerebrovascular permeability X capillary surface area (PA) for the tumor-bearing hemisphere 3 hours after disruption was 1.16 X 10(-6) sec-1 compared to the PA of 0.395 X 10(-6) sec-1 in the nondisrupted hemisphere. Serial brain scans showed that greater than 90% of the radiolabeled antibody cleared from the brain by 72 hours. The highest radiation doses (rads) calculated per 7 mCi injection were: left brain (barrier-modified hemisphere), 5.46; right brain (non-barrier modified hemisphere), 1.68; thyroid, 98; stomach, 9.1; kidney, 39.9; and total body, 1.33. There seemed to be increased uptake of antibody in the tumor region after barrier modification in one patient, but antibody clearance from that region occurred at the same rate as from surrounding and apparently tumor-free brain. In one patient who had carcinomatous meningitis, we demonstrated antibody bound to only a fraction of the antigen binding sites on tumor cells in the cerebrospinal fluid after BBB modification. We have not shown distinct, persistent localization of antibody in brain tumor; studies investigating MAb dose and other parameters as the basis for this problem are under way.

Antibodies, Monoclonal↗

Strontium-90 in bone: a case study in age-dependent dosimetric modeling.

There is an increasing need for age-dependent dosimetric models, and it would be desirable to develop these models in such a way that the uniformity and basic features of the standard man models are retained. Unfortunately, available data concerning the age-dependent retention of nuclides would rarely permit the identification of compartments, uptake fractions, and clearance times using the empirical fitting methods that characterize the development of many adult models. However, in cases where compartments can be made to correspond to physically identifiable processes or subsections within an organ, it may be possible to combine relatively extensive information concerning the development of the human body with generally sparse nuclide-specific information to construct age-dependent compartmental models. In some cases there may be sufficient data to identify trends with age within compartments using empirical fitting techniques, provided the compartments have already been identified on physical bases. To obtain models that describe changes in a continuous manner from birth through adulthood, it may be necessary in many cases to modify existing adult models to consider fewer (or more easily identifiable) compartments. In this article we describe an age-dependent model for retention of ingested 90Sr in bone that exemplifies these concepts.

Adolescent↗